Augustinos Nicholas
AUGUSTINOS NICHOLAS, DIR, reported an open-market or private sale at DEXCOM INC involving 6539.000000 shares for an estimated $549537.56. Reported holdings after the transaction were 29293.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 15, 2026
- Filing date
- Sep 16, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 35,832 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
DXCM price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001093557-26-000179 Common Stock
- Transaction date
- Sep 15, 2026 Filed Sep 16, 2026, 08:26 PM · 1d delay
- Shares
- 6,539 sh $84.04 per share
- Estimated value
- -$549k Computed from shares × price
- Holdings after
- 29,293 sh Indirect · by Trust
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
On June 10, 2026, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 P…
- F2
Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee.
- F3
Represents unvested restricted stock units which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeti…
0 other transactions
0 recent txs